Back
Matthews Emerging Markets Ex Chn Act ETF Vs. NovoCure Industry Stock Comparison
Buy
59
MEMX
Matthews Emerging Markets Ex Chn Act ETF
Last Price:
30.18
Seasonality Move:
7.83%
Buy
74
NVCR
NovoCure
Last Price:
31.11
Seasonality Move:
-5.24%
Buy
59
Matthews Emerging Markets Ex Chn Act ETF (MEMX)
is a Buy
Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $30.18. The Score for MEMX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $31.13. The Score for NVCR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEMX Stock Price Chart
What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?
-
The Matthews Emerging Markets Ex Chn Act ETF share price today is $30.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEMX is experiencing slight buying pressure.
MEMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 53.79 | Buy |
| Chaikin Money Flow: | 912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.61 - 30.19) | Buy |
| Bollinger Bands (100): | (29.65 - 30.81) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.49 | Buy |
| Relative Strength Index (14 RSI): | 74.85 | Buy |
| Chaikin Money Flow: | 740647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.83 - 26.87) | Buy |
| Bollinger Bands (100): | (14.9 - 22.06) | Buy |
MEMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.08 | Buy |
| 20-day SMA: | 29.84 | Buy |
| 50-day SMA: | 30.21 | Sell |
| 200-day SMA: | 29.78 | Buy |
| 8-day EMA: | 30.05 | Buy |
| 20-day EMA: | 30.01 | Buy |
| 50-day EMA: | 30.13 | Buy |
| 200-day EMA: | 29.57 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.21 | Buy |
| 20-day SMA: | 22.23 | Buy |
| 50-day SMA: | 18.67 | Buy |
| 200-day SMA: | 17.74 | Buy |
| 8-day EMA: | 27.96 | Buy |
| 20-day EMA: | 24.04 | Buy |
| 50-day EMA: | 20.52 | Buy |
| 200-day EMA: | 19.64 | Buy |
Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Matthews Emerging Markets Ex Chn Act ETF Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||